Previous close | 0.4300 |
Open | 0.4400 |
Bid | 0.4300 x 0 |
Ask | 0.4350 x 0 |
Day's range | 0.4300 - 0.4400 |
52-week range | 0.4100 - 1.0400 |
Volume | |
Avg. volume | 258,432 |
Market cap | 107.056M |
Beta (5Y monthly) | 1.78 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0340 |
Earnings date | 03 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Archer's biochip in action Archer's biochip in action Highlights Archer has advanced its biochip development by overcoming a conventional limitation preventing many biosensing platforms from becoming broadly useful.The work builds on the significant technology development by the Company to potentially allow for the selective, complex on-chip detection of target biomolecules.Archer has developed software and incorporated hardware with its biochip platform that addresses a fundamental phenomenon t
While Archer Materials Limited ( ASX:AXE ) shareholders are probably generally happy, the stock hasn't had particularly...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...